- Business
- Pony Testing International Group Co., Ltd. is a comprehensive third-party testing, inspection, certification, and technical services provider based in China. Founded in 2002 and headquartered in Beijing, the company provides integrated analytical solutions and quality assurance services across diverse industrial sectors, serving corporate enterprises, research organizations, and regulatory bodies. The company operates an extensive nationwide network of testing bases and specialized laboratories, delivering systematic services that include: life science and healthcare solutions, comprising pharmaceutical contract research and contract development and manufacturing organization (CRO/CDMO) services, active pharmaceutical ingredient testing, clinical and pathological diagnostic testing, toxicology evaluations, biocompatibility assessments, and full-lifecycle medical device verification; food and agricultural product analysis, covering pesticide and veterinary drug residue screening, microbiological examination, nutritional component testing, and food contact material compliance; environmental protection and sustainability services, including ambient air, surface water, groundwater, and soil quality monitoring, ecological risk assessments, hazardous waste identification, ionizing radiation testing, energy-efficiency evaluation, and carbon footprint and carbon neutrality consulting; automotive and new energy testing, providing safety, electromagnetic compatibility (EMC), environmental reliability, and material durability testing for conventional vehicles, new energy vehicles, automotive power batteries, and charging infrastructure; consumer goods and chemical testing, consisting of textile, apparel, footwear, toy, cosmetic efficacy evaluation, cosmetic safety verification, and electronic and electrical product compliance testing; and industrial and engineering services, encompassing metrological calibration, special equipment inspection, factory quality audits, and international market certification support. In recent developments, Pony Testing has strategically accelerated the expansion of high-value business lines by scaling its GLP- and AAALAC-accredited biopharmaceutical CRO/CDMO infrastructure, initiating the Phase II construction of its active pharmaceutical ingredient facility in Hubei, and expanding large-animal and reusable medical device testing capabilities. The company has also deepened strategic partnerships with leading automotive and battery manufacturers to provide comprehensive testing across the entire battery lifecycle and to support domestic electric vehicle makers expanding into overseas markets. Furthermore, Pony Testing broadened its footprint in special equipment and elevator inspection through strategic acquisitions, including the acquisition of Dingshengxin Testing, while expanding technical capabilities into specialized fields such as ionizing radiation detection.